The stock market under Trump has seen one of its worst performances on record in the first 100 days of a U.S. presidency. It’s the worst start to a year since Gerald Ford took over for Richard Nixon 50 years ago,

U.S. stocks were on pace to close out Donald Trump’s first 100 days back in the Oval Office on a sour note, with the president’s trade policies taking the blame for derailing a thriving market and stoking fears the world’s largest economy could slip toward recession.

For a while, the theory that Donald Trump would avoid doing anything that tanked the stock market—named the “Trump put” after an options contract that can protect traders from downside losses—seemed to have failed catastrophically.

Health and wellness company, which sold alternatives to weight-loss drugs like Wegovy, is now collaborating with Wegovy-maker Novo Nordisk.

Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with other services to treat obesity.

Key Takeaways Hims & Hers Health shares surged Tuesday as the company announced a partnership with Danish drugmaker Novo Nordisk.Hims & Hers users will have access to Novo Nordisk's Wegovy starting this week,